Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03228290 · ClinicalTrials.gov registry record

Functional Assessment in Liver Transplantation

A clinical trial of End Stage Liver DIsease, sponsored by University of California, San Francisco.

Recruiting
Registry status
5,000
Enrollment target
12
Study locations

NCT03228290 is a study of End Stage Liver DIsease that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 5,000 participants, above the 179-participant average among 16 other End Stage Liver DIsease trials with a reported enrollment target (2693% higher). The trial reports 12 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03228290, a study of End Stage Liver DIsease, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
5,000 participants
Enrollment target
12
Study locations

Study Summary

This will be a prospective cohort study of patients with liver disease. Subjects will undergo geriatric assessments of frailty, functional status, and disability using functional status measures at baseline and at every clinic visit in the pre-transplant setting. Subjects will also answer questions regarding quality of life, personality, and/or cognitive function. Subjects will again undergo assessments at every clinic visit through 12 months after transplant. Then, they will be followed annually.

Conditions Studied

End Stage Liver DIsease

Study Locations (12)

California

  • Loma Linda University - Loma Linda
  • University of California, San Francisco - San Francisco

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock

Illinois

  • Northwestern University - Chicago

Indiana

  • Indiana University - Indianapolis

Maryland

  • Johns Hopkins - Baltimore

Michigan

  • University of Michigan - Ann Arbor

New York

  • Columbia University - New York

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2011-10-12
Est. Completion 2028-12-31

Sponsor

University of California, San Francisco

1,713 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03228290

The ClinicalTrials.gov registry entry for NCT03228290 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 179-participant average among 16 other End Stage Liver DIsease trials with a reported enrollment target (2693% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End Stage Liver DIsease appearing as the primary indexed condition, and to 0 interventions.

NCT03228290 reports 12 study locations spanning 11 distinct geographic areas - top geographies include California, Arkansas, Illinois.

Frequently Asked Questions

What is clinical trial NCT03228290 about?

NCT03228290 is a clinical study titled "Functional Assessment in Liver Transplantation". This will be a prospective cohort study of patients with liver disease. Subjects will undergo geriatric assessments of frailty, functional status, and disability using functional status measures at baseline and at every clinic visit in the pre-transplant setting. Subjects will also answer questions ...

What is the current status of trial NCT03228290?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2011-10-12. Estimated completion is 2028-12-31.

What conditions does trial NCT03228290 study?

This clinical trial studies the following conditions: End Stage Liver DIsease.

Who is sponsoring clinical trial NCT03228290?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03228290 being conducted?

This trial has 12 study locations across Arkansas, California, Illinois, Indiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Liver DIsease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Liver DIsease

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.